Pharmaceuticals

Phosphoramidite Market Performance Outlook 2026–2030: Revenue to Hit $1.5 Billion at 6.9% CAGR

February 17, 2026February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the phosphoramidite market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Phosphoramidite Market expected to reach by 2030?

The phosphoramidite market has witnessed substantial growth in recent years. Its size is expected to increase from $1.07 billion in 2025 to $1.15 billion in 2026, at a compound annual growth rate (CAGR) of 7.1%. The expansion observed historically stems from factors such as increased DNA sequencing activities, an expansion of academic research funding, the broader application of synthetic nucleic acids, advancements in solid-phase synthesis techniques, and a growing demand for molecular diagnostics.

The phosphoramidite market is projected to experience substantial growth in the upcoming years, with expectations to reach $1.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.9%. This anticipated growth can be attributed to factors such as the expansion of RNA-based therapeutics, advancements in gene editing technologies, increased pharmaceutical R&D investment, a rising demand for custom oligonucleotides, and the scaling of automated synthesis platforms. Prominent trends throughout the forecast period include a heightened demand for oligonucleotide synthesis materials, the broadening scope of gene therapy and RNA therapeutics, their increasing application in diagnostic and research settings, the growing adoption of automated solid-phase synthesis, and an intensified focus on high-purity chemical inputs.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22096&type=smp

What Drivers Are Driving Adoption Within The Phosphoramidite Market?

The burgeoning biopharmaceutical sector is projected to drive the future expansion of the phosphoramidite market. This sector encompasses the industry dedicated to the research, development, manufacturing, and marketing of medical products originating from biological sources, such as vaccines, gene therapies, monoclonal antibodies, and recombinant proteins. Its growth is attributable to progress in biotechnology, a greater incidence of chronic illnesses, and increased funding in research and development. Groundbreaking biotechnology developments, including gene editing and monoclonal antibody therapies, have led to the creation of more effective and precise treatments. As an illustration, the Office for National Statistics, a UK-based government department, stated in October 2025 that the UK life sciences industry in 2024 consisted of 6,170 businesses across 7,320 locations, providing employment for 359,600 individuals and achieving a turnover of $191 billion (£146.9 billion). Medical technology emerged as the leading subsector, both in terms of company numbers and workforce size, accounting for 60% of all companies and 55% of total employment. Consequently, the expanding biopharmaceutical sector is indeed propelling the growth of the phosphoramidite market.

How Is The Phosphoramidite Market Organized Into Various Segments?

The phosphoramidite market covered in this report is segmented –

1) By Type: Deoxyribonucleic Acid (DNA) Phosphoramidites, Ribonucleic Acid (RNA) Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Other Types

2) By Synthesis Method: H-Phosphonate Method, Phosphoramidite Method, Trivalent Phosphorus Compounds Method

3) By Application: Gene Synthesis, Deoxyribonucleic Acid (DNA) Sequencing, Deoxyribonucleic Acid (DNA) Amplification

4) By End-User: Academic Research, Pharmaceutical Industry, Biotechnology Industry

Subsegments:

1) By Deoxyribonucleic Acid (DNA) Phosphoramidites: Standard DNA Phosphoramidites, Degenerate DNA Phosphoramidites, Methylated DNA Phosphoramidites, Backbone-Modified DNA Phosphoramidites

2) By Ribonucleic Acid (RNA) Phosphoramidites: Standard RNA Phosphoramidites, 2′-O-Methyl RNA Phosphoramidites, 2′-Fluoro RNA Phosphoramidites, 2′-O-TBDMS Protected RNA Phosphoramidites

3) By Labeled Phosphoramidites: Fluorescent-Labeled Phosphoramidites, Biotin-Labeled Phosphoramidites, Digoxigenin-Labeled Phosphoramidites, Radioisotope-Labeled Phosphoramidites

4) By Modifier Phosphoramidites: Amine-Modified Phosphoramidites, Thiol-Modified Phosphoramidites, Spacer Phosphoramidites, Azide-Modified Phosphoramidites

5) By Other Types: Chimeric Phosphoramidites, Phosphorothioate Phosphoramidites, PEGylated Phosphoramidites, Photo-Cleavable Phosphoramidites

What Trends Are Reshaping The Dynamics Of The Phosphoramidite Market?

Leading companies in the phosphoramidite market are prioritizing the development of advanced DNA synthesis methods, including convertible-preferred stock financing rounds, to enhance the adoption and progress of Gibson SOLA technology for efficient DNA and mRNA synthesis. Convertible-preferred stock financing refers to a method for raising capital where a company issues preferred shares that can subsequently be exchanged for a predetermined quantity of common shares. For example, in March 2025, Telesis Bio Inc., a US-based biotechnology company, announced it had secured up to $21 million in new financing. This funding aims to expedite the commercialization of its next-generation enzymatic DNA synthesis platform, Gibson SOLA, with backing from several strategic investors. The investment is intended to scale the company’s fully enzymatic DNA synthesis technology, expand its R&D and manufacturing capabilities, and broaden access to rapid, customizable long-DNA production. The company utilizes a proprietary enzymatic approach that allows for the fast and precise synthesis of long DNA sequences, addressing existing bottlenecks associated with traditional phosphoramidite-based methods.

Who Are The Top-Performing Companies In The Phosphoramidite Market In Recent Years?

Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/phosphoramidite-global-market-report

Which Region Currently Holds The Largest Share Of The Phosphoramidite Market?

North America was the largest region in the phosphoramidite market in 2025. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in the phosphoramidite market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Phosphoramidite Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=22096&type=smp

Browse Through More Reports Similar to the Global Phosphoramidite Market 2026, By The Business Research Company

Phosgene Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosgene-global-market-report

Phosphoric Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphoric-acid-global-market-report

Phosphonates Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphonates-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795